Oncology

A topic in the Science corpus, drawn from 9,301 papers.

Trusted voices in Oncology

Ordered by the trust Oncology's own network concentrates on each researcher, most first.

  1. R. Weinberg — trusted by 179 researchers here
  2. D. Pardoll — trusted by 112 researchers here
  3. J. P. Thiery — trusted by 93 researchers here
  4. M. Karin — trusted by 108 researchers here
  5. Zena Werb — trusted by 86 researchers here
  6. A. Mantovani — trusted by 71 researchers here
  7. F. Balkwill — trusted by 69 researchers here
  8. J. Pollard — trusted by 69 researchers here
  9. Karen H. Vousden — trusted by 79 researchers here
  10. J. Massagué — trusted by 64 researchers here
  11. Hans Clevers — trusted by 60 researchers here
  12. Lisa M. Coussens — trusted by 54 researchers here

Most-cited papers in Oncology

Ordered by the recorded citation count from the source corpus; a citation is not an endorsement.

  1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries (2021, Ca) — 96,839 citations
  2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (2018, Ca) — 74,806 citations
  3. Global cancer statistics (2011, Ca) — 65,229 citations
  4. Hallmarks of cancer: the next generation. (2011, Cell) — 63,567 citations
  5. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey (2004, Annals of Surgery) — 30,610 citations
  6. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (2024, Ca) — 29,832 citations
  7. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 (2015, International Journal of Cancer) — 27,202 citations
  8. Clinical Characteristics of Coronavirus Disease 2019 in China (2020, Journal of Emergency Medicine) — 24,808 citations
  9. Global cancer statistics, 2012 (2015, Ca) — 24,749 citations
  10. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study (2020, The Lancet) — 23,319 citations
  11. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 (2010, International Journal of Cancer) — 21,956 citations
  12. Global Cancer Statistics, 2002 (2005, Ca) — 18,664 citations
  13. Cancer statistics, 2020 (2020, Ca) — 18,458 citations
  14. Cancer statistics, 2019 (2019, Ca) — 18,371 citations
  15. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. (2006, Cytotherapy) — 17,261 citations
  16. Cancer statistics, 2018 (2018, Ca) — 15,804 citations
  17. Cancer statistics, 2023 (2023, Ca) — 15,183 citations
  18. Cancer statistics, 2022 (2022, Ca) — 15,111 citations
  19. Cancer statistics in China, 2015 (2016, Ca) — 14,563 citations
  20. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (2010, New England Journal of Medicine) — 14,544 citations
  21. Cancer statistics, 2016 (2016, Ca) — 14,496 citations
  22. Cancer Statistics, 2021 (2021, Ca) — 14,456 citations
  23. Cancer statistics, 2017 (2017, Ca) — 14,452 citations
  24. Cancer Statistics, 2010 (2010, Ca) — 13,209 citations
  25. The blockade of immune checkpoints in cancer immunotherapy (2012, Nature Reviews. Cancer) — 12,881 citations
  26. Dermatologist-level classification of skin cancer with deep neural networks (2017) — 12,830 citations
  27. New guidelines to evaluate the response to treatment in solid tumors (2000, Journal of the National Cancer Institute) — 12,595 citations
  28. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (2012, New England Journal of Medicine) — 11,924 citations
  29. Cancer statistics, 2013 (2013, Ca) — 11,779 citations
  30. Cancer-related inflammation (2008, Nature) — 11,101 citations
  31. Cancer statistics, 2014 (2014, Ca) — 10,985 citations
  32. Cancer statistics, 2012 (2012, Ca) — 10,740 citations
  33. Prospective identification of tumorigenic breast cancer cells (2003, Proceedings of the National Academy of Sciences of the United States of America) — 10,686 citations
  34. Cancer Statistics, 2008 (2008, Ca) — 10,473 citations
  35. Immunity, Inflammation, and Cancer (2010, Cell) — 10,296 citations
  36. Cancer statistics, 2024 (2024, Ca) — 10,166 citations
  37. Cancer statistics, 2015 (2015, Ca) — 10,157 citations
  38. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. (2004, New England Journal of Medicine) — 9,988 citations
  39. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy (2004, Science) — 9,841 citations
  40. Epithelial-mesenchymal transitions in development and disease. (2009, Cell) — 9,583 citations
  41. Stem cells, cancer, and cancer stem cells (2001, Nature) — 9,275 citations
  42. The epithelial-mesenchymal transition generates cells with properties of stem cells. (2008, Cell) — 8,764 citations
  43. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. (2016, New England Journal of Medicine) — 8,730 citations
  44. Prevalence of Childhood and Adult Obesity in the United States, 2011–2012 (2014, Journal of the American Medical Association (JAMA)) — 8,689 citations
  45. Pancreatic cancer. (2013, Clinical Chemistry) — 8,552 citations
  46. Nivolumab versus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer (2015, New England Journal of Medicine) — 8,405 citations
  47. Inferring tumour purity and stromal and immune cell admixture from expression data (2013, Nature Communications) — 7,904 citations
  48. Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies (2001, Tissue engineering) — 7,901 citations
  49. Comprehensive molecular portraits of human breast tumours (2013) — 7,883 citations
  50. Inflammation and cancer (2002, Nature) — 7,865 citations

Most active researchers

By papers in this topic: a volume measure, not trust.